{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:20:42Z","timestamp":1790806842609,"version":"4.1.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Gastroenterol","Clinical and Translational Gastroenterology"],"abstract":"<jats:p>\n                    Small intestinal bacterial overgrowth (SIBO) is a common, yet underrecognized, problem. Its prevalence is unknown because SIBO requires diagnostic testing. Although abdominal bloating, gas, distension, and diarrhea are common symptoms, they do not predict positive diagnosis. Predisposing factors include proton-pump inhibitors, opioids, gastric bypass, colectomy, and dysmotility. Small bowel aspirate\/culture with growth of 10\n                    <jats:sup>3<\/jats:sup>\n                    \u201310\n                    <jats:sup>5<\/jats:sup>\n                    cfu\/mL is generally accepted as the \u201cbest diagnostic method,\u201d but it is invasive. Glucose or lactulose breath testing is noninvasive but an indirect method that requires further standardization and validation for SIBO. Treatment, usually with antibiotics, aims to provide symptom relief through eradication of bacteria in the small intestine. Limited numbers of controlled studies have shown systemic antibiotics (norfloxacin and metronidazole) to be efficacious. However, 15 studies have shown rifaximin, a nonsystemic antibiotic, to be effective against SIBO and well tolerated. Through improved awareness and scientific rigor, the SIBO landscape is poised for transformation.\n                  <\/jats:p>","DOI":"10.14309\/ctg.0000000000000078","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T10:39:28Z","timestamp":1570185568000},"page":"e00078","source":"Crossref","is-referenced-by-count":168,"title":["Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management"],"prefix":"10.14309","volume":"10","author":[{"given":"Satish S. C.","family":"Rao","sequence":"first","affiliation":[{"name":"Augusta University, Augusta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Bhagatwala","sequence":"additional","affiliation":[{"name":"Augusta University, Augusta, Georgia, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"R1-20231218","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.01.003","article-title":"The role of the gut microbiome in the healthy adult status","volume":"451","author":"D'Argenio","year":"2015","journal-title":"Clin Chim Acta"},{"key":"R2-20231218","doi-asserted-by":"crossref","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"key":"R3-20231218","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/srep00170","article-title":"Bacterial biogeography of the human digestive tract","volume":"1","author":"Stearns","year":"2011","journal-title":"Sci Rep"},{"key":"R4-20231218","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0016-5085(69)80067-3","article-title":"Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons","volume":"56","author":"Drasar","year":"1969","journal-title":"Gastroenterology"},{"key":"R5-20231218","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gut.8.6.530","article-title":"Population control in the small bowel","volume":"8","author":"Gorbach","year":"1967","journal-title":"Gut"},{"key":"R6-20231218","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12516","article-title":"Small intestinal bacterial overgrowth: Duodenal aspiration vs glucose breath test","volume":"27","author":"Erdogan","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"R7-20231218","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.12304","article-title":"Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth","volume":"37","author":"Jacobs","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-20231218","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ajg.2017.46","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R9-20231218","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","article-title":"Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture","volume":"33","author":"Choung","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20231218","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-230X-7-29","article-title":"Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy","volume":"7","author":"Hoog","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R11-20231218","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","article-title":"Small intestinal bacterial overgrowth in patients with irritable bowel syndrome","volume":"56","author":"Posserud","year":"2007","journal-title":"Gut"},{"key":"R12-20231218","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MEG.0000000000000122","article-title":"Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture","volume":"26","author":"Ghoshal","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R13-20231218","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10620-012-2033-7","article-title":"The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: Relationship with irritable bowel syndrome","volume":"57","author":"Pyleris","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R14-20231218","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","article-title":"Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome","volume":"95","author":"Pimentel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R15-20231218","first-page":"139","article-title":"Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: Clinical profiles and effects of antibiotic trial","volume":"52","author":"Majewski","year":"2007","journal-title":"Adv Med Sci"},{"key":"R16-20231218","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10620-017-4828-z","article-title":"Association between small intestinal bacterial overgrowth by glucose breath test and coronary artery disease","volume":"63","author":"Fialho","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R17-20231218","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41424-018-0011-x","article-title":"Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?","volume":"9","author":"Rao","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"R18-20231218","doi-asserted-by":"crossref","first-page":"971582","DOI":"10.1155\/2015\/971582","article-title":"Duodenal aspirates for small intestine bacterial overgrowth: Yield, PPIs, and outcomes after treatment at a tertiary academic medical center","volume":"2015","author":"Franco","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R19-20231218","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"Lombardo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20231218","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ajg.2012.4","article-title":"Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth","volume":"107","author":"Ratuapli","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R21-20231218","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1038\/ctg.2015.20","article-title":"Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract","volume":"6","author":"Tsuda","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"R22-20231218","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00535-017-1371-9","article-title":"Meta-analysis: Proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth","volume":"53","author":"Su","year":"2018","journal-title":"J Gastroenterol"},{"key":"R23-20231218","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41424-018-0030-7","article-title":"Brain fogginess, gas and bloating: A link between SIBO, probiotics and metabolic acidosis","volume":"9","author":"Rao","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"R24-20231218","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0004-28032012000400009","article-title":"Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test","volume":"49","author":"Costa","year":"2012","journal-title":"Arq Gastroenterol"},{"key":"R25-20231218","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3109\/00365521.2015.1050691","article-title":"Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response","volume":"50","author":"Greco","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R26-20231218","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5009\/gnl16132","article-title":"Positive glucose breath tests in patients with hysterectomy, gastrectomy, and cholecystectomy","volume":"11","author":"Kim","year":"2017","journal-title":"Gut Liver"},{"key":"R27-20231218","first-page":"530","article-title":"Chronic diarrhoea and diabetes mellitus: Prevalence of small intestinal bacterial overgrowth","volume":"24","author":"Virally-Monod","year":"1998","journal-title":"Diabetes Metab"},{"key":"R28-20231218","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1210\/jc.2007-0606","article-title":"Association between hypothyroidism and small intestinal bacterial overgrowth","volume":"92","author":"Lauritano","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-20231218","doi-asserted-by":"crossref","first-page":"7424831","DOI":"10.1155\/2016\/7424831","article-title":"Prevalence of small intestinal bacterial overgrowth among chronic pancreatitis patients: A case-control study","volume":"2016","author":"Therrien","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R30-20231218","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"key":"R31-20231218","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.sleep.2011.03.007","article-title":"Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth","volume":"12","author":"Weinstock","year":"2011","journal-title":"Sleep Med"},{"key":"R32-20231218","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.14930","article-title":"Rosacea and gastrointestinal disorders: A population-based cohort study","volume":"176","author":"Egeberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"R33-20231218","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2007.01758.x","article-title":"Small intestinal bacterial overgrowth in patients suffering from scleroderma: Clinical effectiveness of its eradication","volume":"103","author":"Parodi","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R34-20231218","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","article-title":"High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: A contributor to severe hepatic steatosis","volume":"18","author":"Sabat\u00e9","year":"2008","journal-title":"Obes Surg"},{"key":"R35-20231218","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2016.11.004","article-title":"Prevalence of small intestinal bacterial overgrowth in multiple sclerosis: A case-control study from China","volume":"301","author":"Zhang","year":"2016","journal-title":"J Neuroimmunol"},{"key":"R36-20231218","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00787-017-1039-2","article-title":"Hydrogen breath test to detect small intestinal bacterial overgrowth: A prevalence case-control study in autism","volume":"27","author":"Wang","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R37-20231218","first-page":"171","article-title":"Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients","volume":"80","author":"Lasa","year":"2015","journal-title":"Rev Gastroenterol Mex"},{"key":"R38-20231218","first-page":"159","article-title":"Small intestinal bacterial overgrowth in North Indian patients with celiac disease","volume":"28","author":"Rana","year":"2007","journal-title":"Trop Gastroenterol"},{"key":"R39-20231218","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MCG.0b013e3181557e67","article-title":"Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease","volume":"43","author":"Rubio-Tapia","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R40-20231218","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","article-title":"Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease","volume":"123","author":"Niu","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"R41-20231218","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.23566","article-title":"Prevalence of small intestinal bacterial overgrowth in Parkinson's disease","volume":"26","author":"Gabrielli","year":"2011","journal-title":"Mov Disord"},{"key":"R42-20231218","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gtc.2016.09.008","article-title":"Small intestinal bacterial overgrowth and other intestinal disorders","volume":"46","author":"Ghoshal","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"R43-20231218","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MEG.0000000000000557","article-title":"A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: A randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghoshal","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R44-20231218","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-015-0436-2","article-title":"Small intestinal fungal overgrowth","volume":"17","author":"Erdogan","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"R45-20231218","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0016-5085(19)33654-6","article-title":"Volume, composition, and source of intestinal gas","volume":"59","author":"Levitt","year":"1970","journal-title":"Gastroenterology"},{"key":"R46-20231218","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1572-0241.2002.05664.x","article-title":"Using breath tests wisely in a gastroenterology practice: An evidence-based review of indications and pitfalls in interpretation","volume":"97","author":"Romagnuolo","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"R47-20231218","first-page":"1","article-title":"Methodology and indications of H2-breath testing in gastrointestinal diseases: The Rome Consensus Conference","volume":"29","author":"Gasbarrini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R48-20231218","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1055\/s-2005-858479","article-title":"Clinically relevant breath tests in gastroenterological diagnostics: Recommendations of the German Society for Neurogastroenterology and Motility as well as the German Society for Digestive and Metabolic Diseases","volume":"43","author":"Keller","year":"2005","journal-title":"Z Gastroenterol"},{"key":"R49-20231218","doi-asserted-by":"crossref","first-page":"S\u2013532","DOI":"10.1016\/S0016-5085(14)61927-2","article-title":"What is the optimal threshold for an increase in hydrogen and methane levels with glucose breath test (GBT) for detection of small intestinal bacterial overgrowth (SIBO)?","volume":"146","author":"Erdogan","year":"2014","journal-title":"Gastroenterology"},{"key":"R50-20231218","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5056\/jnm.2011.17.3.312","article-title":"How to interpret hydrogen breath tests","volume":"17","author":"Ghoshal","year":"2011","journal-title":"J Neurogastroenterol Motil"},{"key":"R51-20231218","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2015.07.032","article-title":"Scintigraphy demonstrates high rate of false-positive results from glucose breath tests for small bowel bacterial overgrowth","volume":"14","author":"Lin","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R52-20231218","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.cgh.2013.09.055","article-title":"Breath testing for small intestinal bacterial overgrowth: Maximizing test accuracy","volume":"12","author":"Saad","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R53-20231218","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1016\/S0016-5085(17)31609-8","article-title":"Endoscopically assisted glucose breath test (EAGBT): A novel diagnostic approach for distal sibo","volume":"152","author":"Viswanathan","year":"2017","journal-title":"Gastroenterol"},{"key":"R54-20231218","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41928-017-0004-x","article-title":"A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut","volume":"1","author":"Kalantar-Zadeh","year":"2018","journal-title":"Nat Electronics"},{"key":"R56-20231218","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R57-20231218","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3346\/jkms.2015.30.6.757","article-title":"Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects","volume":"30","author":"Bae","year":"2015","journal-title":"J Korean Med Sci"},{"key":"R58-20231218","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12941-014-0049-x","article-title":"Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome","volume":"13","author":"Boltin","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R59-20231218","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7453\/gahmj.2014.019","article-title":"Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"3","author":"Chedid","year":"2014","journal-title":"Glob Adv Health Med"},{"key":"R60-20231218","first-page":"143","article-title":"Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin: A pilot study","volume":"51","author":"Moraru","year":"2013","journal-title":"Rom J Intern Med"},{"key":"R61-20231218","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/15748847113089990048","article-title":"Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: A comparative evaluation","volume":"8","author":"Rosania","year":"2013","journal-title":"Curr Clin Pharmacol"},{"key":"R62-20231218","first-page":"111","article-title":"Antibiotic therapy in small intestinal bacterial overgrowth: Rifaximin versus metronidazole","volume":"13","author":"Lauritano","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R63-20231218","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2036.2007.03259.x","article-title":"High dosage rifaximin for the treatment of small intestinal bacterial overgrowth","volume":"25","author":"Scarpellini","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R64-20231218","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2005.02516.x","article-title":"Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth","volume":"22","author":"Lauritano","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R65-20231218","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2036.2000.00751.x","article-title":"Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R66-20231218","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/030006058801600410","article-title":"Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin","volume":"16","author":"Corazza","year":"1988","journal-title":"J Int Med Res"},{"key":"R67-20231218","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: Rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R68-20231218","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/apt.12087","article-title":"Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months","volume":"36","author":"Meyrat","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R69-20231218","first-page":"604","article-title":"Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)\u2013A pilot study","volume":"140","author":"Khalighi","year":"2014","journal-title":"Indian J Med Res"},{"key":"R70-20231218","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2036.2005.02562.x","article-title":"Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis","volume":"22","author":"Sajjad","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R71-20231218","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1046\/j.1365-2036.2003.01800.x","article-title":"Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease","volume":"18","author":"Castiglione","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R72-20231218","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1572-0241.2001.03636.x","article-title":"Long-term treatment with cisapride and antibiotics in liver cirrhosis: Effect on small intestinal motility, bacterial overgrowth, and liver function","volume":"96","author":"Madrid","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R73-20231218","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0016-5085(99)70336-7","article-title":"Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial","volume":"117","author":"Attar","year":"1999","journal-title":"Gastroenterology"},{"key":"R74-20231218","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/MEG.0000000000000214","article-title":"Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease","volume":"26","author":"Kwak","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R75-20231218","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00365549609037970","article-title":"Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD","volume":"28","author":"Stotzer","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"R76-20231218","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: A randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R77-20231218","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: A meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"R78-20231218","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41424-018-0057-9","article-title":"\u201cBrain fogginess\u201d and D-lactic acidosis: Probiotics are not the cause","volume":"9","author":"Quigley","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"R79-20231218","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ajcn\/23.5.546","article-title":"Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations","volume":"23","author":"Winitz","year":"1970","journal-title":"Am J Clin Nutr"},{"key":"R80-20231218","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:DDAS.0000011605.43979.e1","article-title":"A 14-day elemental diet is highly effective in normalizing the lactulose breath test","volume":"49","author":"Pimentel","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R81-20231218","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","article-title":"A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome","volume":"113","author":"Dionne","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R82-20231218","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1572-0241.2008.02030.x","article-title":"Small intestinal bacterial overgrowth recurrence after antibiotic therapy","volume":"103","author":"Lauritano","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R83-20231218","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: Pathogenesis and clinical significance","volume":"4","author":"Sachdev","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"key":"R84-20231218","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.2008.03249.x","article-title":"Cisapride and ventricular arrhythmia","volume":"66","author":"Hennessy","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R85-20231218","first-page":"435","article-title":"Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth","volume":"5","author":"Pimentel","year":"2009","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R86-20231218","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: A systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R87-20231218","first-page":"S7","article-title":"How useful is histological testing of disaccharidase deficiency in the evaluation of unexplained GI symptoms in adults?","volume":"152","author":"Viswanathan","year":"2017","journal-title":"AGA Abstracts"},{"key":"R88-20231218","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2016.03.005","article-title":"Letter to the editor: It's all in the mix: Diagnosis and management of food intolerance","volume":"14","author":"Philpott","year":"2016","journal-title":"Clin Gastro Hepatol"},{"key":"R89-20231218","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jgh.13015","article-title":"Poor predictive value of breath hydrogen response for probiotic effects in IBS","volume":"30","author":"Yao","year":"2015","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinical and Translational Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.14309\/ctg.0000000000000078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:11:03Z","timestamp":1786543863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.14309\/ctg.0000000000000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":88,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/ctg.0000000000000078","relation":{},"ISSN":["2155-384X"],"issn-type":[{"value":"2155-384X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}